Emerging research suggest Retatru tide , a dual stimulator targeting both the gut-brain axis and GIP , could provide a notable step forward for body management . Initial patient tests have shown substantial decreases in visceral tissue, possibly outperforming existing weight-loss medications . Nevertheless , more assessment is required to fully det